Femasys

FEMY · NASDAQ

$1.67+$0.04 (+2.45%)TodayMarket closed ·
Prev close $1.63

About FEMY

The company is headquartered in Suwanee, Georgia and currently employs 51 full-time employees. The company went IPO on 2021-06-18.

Employees
51
Headquarters
Suwanee, Georgia
Listed
Jun 18, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies

FEMY key statistics

Market cap
13.99M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
104.96K
Volume
34.01K
Open price
$1.65
High today
$1.77
Low today
$1.58
52 Week high
$22.20
52 Week low
$1.46

Femasys (FEMY) at a glance

Femasys (FEMY) last traded at $1.67, with a market cap of 13.99M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.58 and $1.77. The current price is 5.7% above the day's low and 5.6% below its high.

Volume so far is 34.01K shares, below the average of 104.96K shares a day.

Over the past year Femasys has ranged from $1.46 to $22.20, and now sits 1% of the way up that range.

Femasys met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$1.55 per share against an estimate of -$1.33.

The average analyst price target is $14.62, 775.4% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 3 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $14.62
Low
$10.10
Now
$1.67
High
$24.15

FEMY earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 41.6% on average.

  1. Q3 FY24: reported -$4.80 per share against an estimate of -$4.08
  2. Q4 FY24: reported -$4.60 per share against an estimate of -$3.77
  3. Q1 FY25: reported -$4.60 per share against an estimate of -$3.88
  4. Q2 FY25: reported -$3.00 per share against an estimate of -$3.67
  5. Q3 FY25: reported -$2.00 per share against an estimate of -$2.65
  6. Q4 FY25: reported -$0.20 per share against an estimate of -$1.78
  7. Q1 FY26: reported -$1.20 per share against an estimate of -$1.84
  8. Q2 FY26: reported -$1.55 per share against an estimate of -$1.33

FEMY news

  • Vandana Singh

    Femasys Secures FDA Pathway for Non-Surgical Contraceptive

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • 12 Health Care Stocks Moving In Friday's After-Market Session

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

  • 12 Health Care Stocks Moving In Friday's After-Market Session

Similar companies

Companies in the same industry as Femasys

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.